Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 154.00
+1.50 (0.98%)
May 15, 2025, 12:04 PM IDT
Novolog (Pharm-Up 1966) Revenue
In the year 2024, Novolog (Pharm-Up 1966) had annual revenue of 2.02B ILS with 23.01% growth. Novolog (Pharm-Up 1966) had revenue of 689.88M in the quarter ending December 31, 2024, with 74.01% growth.
Revenue
2.02B
Revenue Growth
+23.01%
P/S Ratio
0.39
Revenue / Employee
2.16M
Employees
936
Market Cap
779.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.02B | 378.11M | 23.01% |
| Dec 31, 2023 | 1.64B | 135.54M | 8.99% |
| Dec 31, 2022 | 1.51B | 252.70M | 20.13% |
| Dec 31, 2021 | 1.26B | 121.61M | 10.73% |
| Dec 31, 2020 | 1.13B | 129.51M | 12.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 61.87B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 622.70M |
| Bait Bakfar | 103.40M |
| SofWave Medical | 235.09M |
| Ilex Medical | 920.37M |
| BrainsWay | 161.81M |
| Epitomee Medical | 37.17M |